Document is current
Any future updates will be listed below
-
Authors
Lanz, Henriette L.
Saleh, Anthony
Kramer, Bart
Cairns, Junmei
Ng, Chee Ping
Yu, Jia
Trietsch, Sebastiaan J.
Hankemeier, Thomas
Joore, Jos
Vulto, Paul
Weinshilboum, Richard
Wang, Liewei
-
Funding
Funding for this research was provided by:
National Institutes of Health (RO1 CA196640, U19 GM61388, U19 GM61388)
Mayo Clinic (Center for Individualized Medicine Pharmacogenomics Translational Program)
Mayo Clinic (Center for Individualized Medicine Pharmacogenomics Translational Program)
- License Information
-
More Information
Article History
Received: 12 May 2016
Accepted: 27 October 2017
First Online: 2 November 2017
Ethics approval and consent to participate
: The generation of the breast cancer PDX models were described previously [CitationRef removed]. The Mayo Clinic Institutional Animal Care and Use Committee (IACUC) reviewed and approved all of the mouse experiments for the PDX tumors used in this study.
: Not applicable
: Paul Vulto, Jos Joore, Thomas Hankemeier and Sebastiaan J Trietsch have ownership interest in Mimetas B.V, which has developed the technology reported in this publication. Henriette Lanz, Anthony Saleh, Bart Kramer and Chee Ping Ng are employees of Mimetas B.V.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
